BBIO
USDBridgeBio Pharma Inc. Common Stock
实时价格
价格图表
关键指标
市场指标
开盘价
$61.420
最高价
$61.905
最低价
$60.230
成交量
2.10M
公司基本面
市值
11.8B
所属行业
生物技术
国家/地区
United States
交易统计
平均成交量
2.63M
交易所
NMS
货币
USD
52周价格范围
相关新闻
BridgeBio to Participate in November Investor Conferences
PALO ALTO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ:BBIO) ("BridgeBio" or the "Company"), a new type of biopharmaceutical company focused on genetic diseases, today announced that
BridgeBio to Present Data from the Overall ATTR-CM Variant and V142I (V122I) Populations from ATTRibute-CM at the AHA Scientific Sessions 2025
PALO ALTO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (NASDAQ:BBIO) ("BridgeBio" or the "Company"), a new type of biopharmaceutical company focused on genetic diseases, announced today that ten
HC Wainwright & Co. Reiterates Buy on BridgeBio Pharma, Maintains $90 Price Target
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates BridgeBio Pharma with a Buy and maintains $90 price target.
Goldman Sachs Maintains Buy on BridgeBio Pharma, Raises Price Target to $100
Goldman Sachs analyst Paul Choi maintains BridgeBio Pharma with a Buy and raises the price target from $55 to $100.
TD Cowen Maintains Buy on BridgeBio Pharma, Raises Price Target to $95
TD Cowen analyst Tyler Van Buren maintains BridgeBio Pharma with a Buy and raises the price target from $60 to $95.
Raymond James Reiterates Outperform on BridgeBio Pharma, Raises Price Target to $71
Raymond James analyst Martin Auster reiterates BridgeBio Pharma with a Outperform and raises the price target from $69 to $71.
Cantor Fitzgerald Maintains Overweight on BridgeBio Pharma, Raises Price Target to $110
Cantor Fitzgerald analyst Josh Schimmer maintains BridgeBio Pharma with a Overweight and raises the price target from $100 to $110.
